MUFG Securities EMEA’s Charles River Laboratories CRL Stock Holding History

MUFG Securities EMEA’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$427K	Sell	1,885 -135	-7%	-$24K	﹤0.01%	542
2026 Q1	$348K	Hold	2,020	–	–	0.01%	525
2025 Q4	$403K	Buy	2,020 +1,078	+114%	+$196K	﹤0.01%	533
2025 Q3	$147K	Buy	942 +791	+524%	+$126K	﹤0.01%	530
2025 Q2	$22.9K	Buy	+151	New	+$20.1K	﹤0.01%	527
2021 Q2	–	Sell	-14,000	Closed	-$4.06M	–	319
2021 Q1	$4.06M	Sell	14,000 -10,000	-42%	-$2.78M	0.03%	238
2020 Q4	$6M	Buy	+24,000	New	+$5.72M	0.05%	196
2020 Q3	–	Sell	-44,000	Closed	-$7.67M	–	401
2020 Q2	$7.67M	Sell	44,000 -15,000	-25%	-$2.39M	0.07%	180
2020 Q1	$7.45M	Buy	59,000 +17,400	+42%	+$2.61M	0.08%	170
2019 Q4	$6.36M	Buy	41,600 +34,000	+447%	+$4.71M	0.05%	251
2019 Q3	$1.01M	Buy	+7,600	New	+$1.02M	0.01%	276

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

MUFG Securities EMEA's CRL Position: Q2 2026 in Review

MUFG Securities EMEA reduced its Charles River Laboratories (CRL) stake by 6.7% in Q2 2026, selling an estimated $24K and leaving 1,885 shares worth $427K. The position accounts for ﹤0.01% of the portfolio, ranked #542.

MUFG Securities EMEA first reported a position in CRL in Q3 2019 and has held it in 11 quarters since. The position peaked at $7.67M in Q2 2020. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

MUFG Securities EMEA held 1,885 shares of Charles River Laboratories worth $427K as of Q2 2026.
MUFG Securities EMEA sold 135 Charles River Laboratories shares in Q2 2026, an estimated $24K.
Charles River Laboratories made up ﹤0.01% of MUFG Securities EMEA's portfolio in Q2 2026, its #542 holding.
MUFG Securities EMEA first reported a position in Charles River Laboratories in Q3 2019 and has held it in 11 quarters since.
MUFG Securities EMEA's Charles River Laboratories position peaked at $7.67M in Q2 2020.
565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.